Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel
- 1 August 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (3), 527-532
- https://doi.org/10.1016/0006-2952(92)90445-o
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Ticlopidine and Clopidogrel (SR 25990C) Selectively Neutralize ADP Inhibition of PGE1-Activated Platelet Adenylate Cyclase in Rats and RabbitsThrombosis and Haemostasis, 1991
- The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb–IIIa complex in rat and in manBiochemical Pharmacology, 1990
- Pharmacology of Ticlopidine: A ReviewSeminars in Thrombosis and Hemostasis, 1989
- Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADPThrombosis Research, 1987
- TiclopidineDrugs, 1987
- Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.Journal of Clinical Investigation, 1985
- Enterohepatic circulation of indomethacin and its role in intestinal irritationBiochemical Pharmacology, 1975
- Eine vereinfachte Methode zur funktionellen HepatektomiePflügers Archiv - European Journal of Physiology, 1967
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962